# Phase I Study of HS-20108 in Participants With Advanced Solid Tumors

> **NCT06936735** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Hansoh BioMedical R&D Company** · enrollment: 502 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** HS-20108 Monotherapy

## Key facts

- **NCT ID:** NCT06936735
- **Lead sponsor:** Hansoh BioMedical R&D Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-17
- **Primary completion:** 2027-10-28
- **Final completion:** 2027-11-27
- **Target enrollment:** 502 (ESTIMATED)
- **Last updated:** 2025-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06936735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06936735, "Phase I Study of HS-20108 in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06936735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*